MK-2206 2HCl
- CAS编号: 1032350-13-2
- 分子式: C25H21N5O·2HCl
- 分子量: 480.39
- PubChem编号: 46930998
库存信息
库存信息
库存信息
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
M129684-10mg | 10mg | 现货 | | |
M129684-50mg | 50mg | 现货 | | |
M129684-100mg | 100mg | 现货 | |
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
M129684-10mg | 10mg | 现货 | | |
M129684-50mg | 50mg | 现货 | | |
M129684-100mg | 100mg | 现货 | |
规格或纯度 | ≥98% |
---|---|
英文名称 | MK-2206 2HCl |
别名 | MK2206 |
英文别名 | MK2206;MK-2206 dihydrochloride;8-[4-(1-Aminocyclobutyl)phenyl]-9-phenyl-1,2,4-triazolo[3,4-f][1,6]naphthyridin-3(2H)-one dihydrochloride |
生化机理 | MK-2206 2HCl is a highly selective inhibitor of Akt1, Akt2, and Akt3 with IC50 values of 8 nM, 12 nM and 65 nM, respectively. MK-2206 is an allosteric inhibitor and is activated by the pleckstrin homology domain. MK-2206 inhibits auto-phosphorylation of both Akt T308 and S473. MK-2206 also prevents Akt-mediated phosphorylation of downstream signaling molecules, including TSC2, PRAS40 and ribosomal S6 proteins. MK-2206 also shows synergistic responses in combination with cytotoxic agents such as erlotinib or lapatinib in lung NCI-H460 or ovarian A2780 tumor cells |
应用 | A highly selective pan-Akt inhibitor activated by the pleckstrin homology domain |
储存温度 | -20°C储存,充氩 |
运输条件 | 超低温冰袋运输 |
产品介绍 |
MK-2206 2HCl是一种高度选择性的Akt1/2/3抑制剂,IC50分别为8 nM/12 nM/65 nM;对250种其他蛋白激酶没有抑制活性。A highly selective pan-Akt inhibitor activated by the pleckstrin homology domain MK-2206 2HCl is a highly selective inhibitor of Akt1/2/3 with IC50 of 8 nM/12 nM/65 nM, respectively; no inhibitory activities against 250 other protein kinases observed. |
IUPAC Name | 8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl-2H-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3-one;dihydrochloride |
---|---|
INCHI | InChI=1S/C25H21N5O.2ClH/c26-25(12-4-13-25)18-9-7-17(8-10-18)22-19(16-5-2-1-3-6-16)15-20-21(27-22)11-14-30-23(20)28-29-24(30)31;;/h1-3,5-11,14-15H,4,12-13,26H2,(H,29,31);2*1H |
InChi Key | HWUHTJIKQZZBRA-UHFFFAOYSA-N |
Canonical SMILES | C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N.Cl.Cl |
分子式 |
C25H21N5O·2HCl |
PubChem CID | 46930998 |
分子量 | 480.39 |
PubChem CID | 24964624 |
---|---|
ChEBI | CHEBI:67271 |
CAS Registry No. | 1032350-13-2 |
ChEMBL Ligand | CHEMBL1079175 |
Reactome Reaction | R-HSA-2400010 |
Reactome Drug | R-ALL-2399927 |
溶解性 | Soluble in DMSO (≥92 mg/ml), water (≥92 mg/ml), ethanol (≥1.8 mg/ml), and methanol. |
---|---|
敏感性 | 对湿度敏感 |
熔点 | >225°C |
Target ID | 1479 | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
名称 | AKT serine/threonine kinase 1 | ||||||||||||||||||||||||
缩写名 | Akt1 | ||||||||||||||||||||||||
家族 | Akt (Protein kinase B, PKB) family | ||||||||||||||||||||||||
别名 | Gpcr17 | ||||||||||||||||||||||||
基因和蛋白信息 |
|
||||||||||||||||||||||||
Ensembl Gene | ENSG00000142208 (Hs) , ENSMUSG00000001729 (Mm) , ENSRNOG00000028629 (Rn) | ||||||||||||||||||||||||
Entrez Gene | 11651 (Mm) , 24185 (Rn) , 207 (Hs) | ||||||||||||||||||||||||
OMIM | 164730 (Hs) | ||||||||||||||||||||||||
Protein GI | 15100164 (Rn) , 62241015 (Hs) , 260166608 (Mm) | ||||||||||||||||||||||||
UniProtKB | P31749 (Hs) , P31750 (Mm) , P47196 (Rn) | ||||||||||||||||||||||||
RefSeq Nucleotide | NM_001014431 (Hs) , NM_009652 (Mm) , NM_033230 (Rn) | ||||||||||||||||||||||||
RefSeq Protein | NP_001014431 (Hs) , NP_001159366 (Mm) , NP_033782 (Mm) , NP_150233 (Rn) | ||||||||||||||||||||||||
Orphanet | 281472 (Hs) | ||||||||||||||||||||||||
CATH/Gene3D | 2.30.29.30 (N/A) | ||||||||||||||||||||||||
ChEMBL Target | CHEMBL4282 (Hs) , CHEMBL1075215 (Rn) , CHEMBL5859 (Mm) |
Target ID | 1480 | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
名称 | AKT serine/threonine kinase 2 | ||||||||||||||||||||||||
缩写名 | Akt2 | ||||||||||||||||||||||||
家族 | Akt (Protein kinase B, PKB) family | ||||||||||||||||||||||||
别名 | Gpcr17 | ||||||||||||||||||||||||
基因和蛋白信息 |
|
||||||||||||||||||||||||
Ensembl Gene | ENSG00000105221 (Hs) , ENSMUSG00000004056 (Mm) , ENSRNOG00000018677 (Rn) | ||||||||||||||||||||||||
Entrez Gene | 11652 (Mm) , 25233 (Rn) , 208 (Hs) | ||||||||||||||||||||||||
OMIM | 164731 (Hs) | ||||||||||||||||||||||||
Protein GI | 8392888 (Rn) , 339895855 (Hs) , 158937315 (Mm) | ||||||||||||||||||||||||
UniProtKB | P31751 (Hs) , P47197 (Rn) , Q60823 (Mm) | ||||||||||||||||||||||||
RefSeq Nucleotide | NM_001243027 (Hs) , NM_007434 (Mm) , NM_017093 (Rn) | ||||||||||||||||||||||||
RefSeq Protein | NP_001103678 (Mm) , NP_001617 (Hs) , NP_031460 (Mm) , NP_058789 (Rn) | ||||||||||||||||||||||||
Orphanet | 201112 (Hs) | ||||||||||||||||||||||||
CATH/Gene3D | 2.30.29.30 (N/A) | ||||||||||||||||||||||||
ChEMBL Target | CHEMBL5382 (Mm) , CHEMBL2431 (Hs) |
Target ID | 2286 | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
名称 | AKT serine/threonine kinase 3 | ||||||||||||||||||||||||
缩写名 | AKT3 | ||||||||||||||||||||||||
家族 | Akt (Protein kinase B, PKB) family | ||||||||||||||||||||||||
别名 | Gpcr17 | ||||||||||||||||||||||||
基因和蛋白信息 |
|
||||||||||||||||||||||||
Entrez Gene | 10000 (Hs) , 23797 (Mm) , 29414 (Rn) | ||||||||||||||||||||||||
UniProtKB | Q9Y243 (Hs) , Q9WUA6 (Mm) , Q63484 (Rn) | ||||||||||||||||||||||||
Ensembl Gene | ENSG00000117020 (Hs) , ENSMUSG00000019699 (Mm) , ENSRNOG00000021497 (Rn) | ||||||||||||||||||||||||
RefSeq Nucleotide | NM_005465 (Hs) , NM_011785 (Mm) , NM_031575 (Rn) | ||||||||||||||||||||||||
RefSeq Protein | NP_005456 (Hs) , NP_035915 (Mm) , NP_113763 (Rn) | ||||||||||||||||||||||||
OMIM | 611223 (Hs) | ||||||||||||||||||||||||
Orphanet | 299660 (Hs) | ||||||||||||||||||||||||
Protein GI | 4885549 (Hs) , 190883484 (Mm) , 13928778 (Rn) | ||||||||||||||||||||||||
CATH/Gene3D | 2.30.29.30 (N/A) | ||||||||||||||||||||||||
ChEMBL Target | CHEMBL4816 (Hs) |
Ligand ID | 7945 |
---|---|
名称 | MK-2206 |
别名 | MK 2206 |
类别 | Synthetic organic |
学名 | 8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl-2H-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3-one |
生物活性评价 |
MK-2206 is able to enhance the antitumor efficacy of standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo |
评价 |
MK-2206 is an orally bioavailable allosteric inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity |
1. Hirai H, Sootome H, Nakatsuru Y, Miyama K, Taguchi S, Tsujioka K, Ueno Y, Hatch H, Majumder PK, Pan BS et al.. (2010) MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo.. Mol Cancer Ther, 9 (7): (1956-67). [PMID:20571069] |
2. Liu R, Liu D, Trink E, Bojdani E, Ning G, Xing M. (2011) The Akt-specific inhibitor MK2206 selectively inhibits thyroid cancer cells harboring mutations that can activate the PI3K/Akt pathway.. J Clin Endocrinol Metab, 96 (4): (E577-85). [PMID:21289267] |
3. Lin YH, Chen BY, Lai WT, Wu SF, Guh JH, Cheng AL, Hsu LC. (2015) The Akt inhibitor MK-2206 enhances the cytotoxicity of paclitaxel (Taxol) and cisplatin in ovarian cancer cells.. Naunyn Schmiedebergs Arch Pharmacol, 388 (1): (19-31). [PMID:25164962] |
4. Holland WS, Chinn DC, Lara Jr PN, Gandara DR, Mack PC. (2015) Effects of AKT inhibition on HGF-mediated erlotinib resistance in non-small cell lung cancer cell lines.. J Cancer Res Clin Oncol, 141 (4): (615-26). [PMID:25323938] |